Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20008913 | 0.82 | NPSR1 (0.57) | NPSR1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL12376770 | 0.80 | NPSR1 (0.43) | NPSR1ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL18775993 | 0.79 | NPSR1 (0.44) | NPSR1ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL10172880 | 0.77 | ALDH1A1 (0.53) | NPSR1ALDH1A1GAAL3MBTL1POLB | |
| SCHEMBL98471 | 0.77 | ALDH1A1 (0.47) | NPSR1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL16722815 | 0.75 | GAA (0.58) | ALDH1A1THRBGAAMEN1KMT2A | |
| SCHEMBL18775888 | 0.75 | NPSR1 (0.47) | NPSR1ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL10447425 | 0.74 | NPSR1 (0.42) | NPSR1ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL12409643 | 0.74 | NPSR1 (0.43) | NPSR1ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL21281793 | 0.72 | NPSR1 (0.40) | NPSR1ALDH1A1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SLC9A1, FN1, EPCAM | NPSR1 1435/4885ALDH1A1 749/4885THRB 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.